Mustapha Chamekh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mustapha Chamekh has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Georges Casimir
Inflammation Unit, Laboratory of Pediatric Research, Faculty of Medicine, Université Libre de Bruxelles, Brussels, Belgium
4 shared publicationsMarta Romano
Immune Response service, Sciensano, Brussels, Belgium
3 shared publicationsMaud Deny
Inflammation Unit, Laboratory of Pediatric Research, Faculty of Medicine, Université Libre de Bruxelles, Brussels, Belgium
2 shared publicationsOlivier Denis
Immune Response service, Sciensano, Brussels, Belgium
2 shared publicationsAbdelmounaaïm Allaoui
Laboratoire de Bactériologie Moléculaire, Université Libre de Bruxelles , Brussels
1 shared publication- Amal Badre
Neonatal Reanimation Department (P4), Children's Hospital A. Harouchi, CHU Ibn Rochd, Faculty of Medicine and Pharmacy of Casablanca, Hassan II University of Casablanca , Casablanca
1 shared publication
Latest Publications
- 11 February 2026
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 233 (5) , 888-898
Inflammatory Cytokine Profile in Pregnant Women Colonized With Group B Streptococcus Reveals IL-17a as a Potential Biomarker to Identify at-risk Newborns
Background: Group B Streptococcus (GBS) is a commensal vaginal bacterium that can lead to adverse maternal and neonatal outcomes. In low or middle-income countries, few data are available regarding the immune-inflammatory response in GBS-colonized pregnant mothers and its association with the risk of neonatal invasive disease. In this investigation, we implement a prospective study on a cohort of mother–newborn dyads in Morocco to assess the cytokine profile in GBS-colonized-mothers whose newborns have invasive GBS disease. Methods: Pregnant women between 35 and 40 weeks of gestation were screened for vaginal colonization by GBS and followed up until delivery. A panel of inflammatory cytokines was quantified by Luminex multiplex assays and by ELISA in maternal and cord blood, as well as in supernatants after stimulation of pathogen recognition receptors. GBS-colonized-mothers were clustered according to clinical and inflammation markers and to their newborn's infection status. Results: GBS-colonized-mothers whose newborns developed invasive GBS disease exhibited significantly lower IL-1β, IL-4, and IL-17A production compared with GBS-colonized-mothers with healthy newborns. Similar results were obtained following ex vivo stimulation of peripheral blood cells by TLR4 and TLR1/2 ligands. The level of circulating maternal IL-17A had a higher significant predictive value for GBS transmission leading to invasive neonatal disease. Conclusions: This study shows that GBS-colonized-mothers may exhibit a greater cytokine inflammatory response compared with noncolonized-mothers. Regarding mother–newborn dyads, maternal IL-17A, a key mediator of antibacterial defense, emerges as a significant prognostic biomarker for assessing the risk of GBS transmission and the development of neonatal GBS invasive disease.
- 11 February 2026
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 233 (5) , 888-898
Inflammatory Cytokine Profile in Pregnant Women Colonized With Group B Streptococcus Reveals IL-17a as a Potential Biomarker to Identify at-risk Newborns
Background: Group B Streptococcus (GBS) is a commensal vaginal bacterium that can lead to adverse maternal and neonatal outcomes. In low or middle-income countries, few data are available regarding the immune-inflammatory response in GBS-colonized pregnant mothers and its association with the risk of neonatal invasive disease. In this investigation, we implement a prospective study on a cohort of mother–newborn dyads in Morocco to assess the cytokine profile in GBS-colonized-mothers whose newborns have invasive GBS disease. Methods: Pregnant women between 35 and 40 weeks of gestation were screened for vaginal colonization by GBS and followed up until delivery. A panel of inflammatory cytokines was quantified by Luminex multiplex assays and by ELISA in maternal and cord blood, as well as in supernatants after stimulation of pathogen recognition receptors. GBS-colonized-mothers were clustered according to clinical and inflammation markers and to their newborn's infection status. Results: GBS-colonized-mothers whose newborns developed invasive GBS disease exhibited significantly lower IL-1β, IL-4, and IL-17A production compared with GBS-colonized-mothers with healthy newborns. Similar results were obtained following ex vivo stimulation of peripheral blood cells by TLR4 and TLR1/2 ligands. The level of circulating maternal IL-17A had a higher significant predictive value for GBS transmission leading to invasive neonatal disease. Conclusions: This study shows that GBS-colonized-mothers may exhibit a greater cytokine inflammatory response compared with noncolonized-mothers. Regarding mother–newborn dyads, maternal IL-17A, a key mediator of antibacterial defense, emerges as a significant prognostic biomarker for assessing the risk of GBS transmission and the development of neonatal GBS invasive disease.
- Open Access
- 11 October 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-14
Sex difference in innate inflammatory response and macrophage polarization in Streptococcus agalactiae-induced pneumonia and potential role of microRNA-223-3p
While number of studies have shown that biological sex is a risk factor in the incidence and severity of infection-induced inflammatory diseases, the underlying mechanisms are still poorly understood. In this study, we compared the innate inflammatory response in male and female mice with group B streptococcal (GBS)-induced pneumoniae. Although male and female mice displayed similar bacterial burdens, males exhibited more innate inflammatory cytokines and chemokines and a higher proportion of infiltrating monocytes/macrophages. The analysis of the distribution of macrophage subtypes M1 (pro-inflammatory) versus M2 (anti-inflammatory) yielded a higher M1/M2 ratio in infected males compared with females. Given the importance of the chromosome X-linked microRNA-223-3p (miR-223-3p) in modulating the inflammatory process and macrophage polarization, we investigated its potential contribution in sex bias of GBS-induced innate inflammatory response. Knock-down of miR-223-3p with specific antagomiR resulted in increased inflammatory response and higher M1/M2 ratio following GBS infection. Notably, compared to male mice, we detected higher amount of miR-223-3p in macrophages from females that correlated negatively with M1 phenotype. These results suggest that differential expression of miR-233-3p may impact macrophage polarization, thereby contributing to fine-tune sex differences in inflammatory response.
- 11 October 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-14
Open AccessSex difference in innate inflammatory response and macrophage polarization in Streptococcus agalactiae-induced pneumonia and potential role of microRNA-223-3p
While number of studies have shown that biological sex is a risk factor in the incidence and severity of infection-induced inflammatory diseases, the underlying mechanisms are still poorly understood. In this study, we compared the innate inflammatory response in male and female mice with group B streptococcal (GBS)-induced pneumoniae. Although male and female mice displayed similar bacterial burdens, males exhibited more innate inflammatory cytokines and chemokines and a higher proportion of infiltrating monocytes/macrophages. The analysis of the distribution of macrophage subtypes M1 (pro-inflammatory) versus M2 (anti-inflammatory) yielded a higher M1/M2 ratio in infected males compared with females. Given the importance of the chromosome X-linked microRNA-223-3p (miR-223-3p) in modulating the inflammatory process and macrophage polarization, we investigated its potential contribution in sex bias of GBS-induced innate inflammatory response. Knock-down of miR-223-3p with specific antagomiR resulted in increased inflammatory response and higher M1/M2 ratio following GBS infection. Notably, compared to male mice, we detected higher amount of miR-223-3p in macrophages from females that correlated negatively with M1 phenotype. These results suggest that differential expression of miR-233-3p may impact macrophage polarization, thereby contributing to fine-tune sex differences in inflammatory response.
- 16 November 2020
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 88 (12)
Progressive Control of Streptococcus agalactiae-Induced Innate Inflammatory Response Is Associated with Time Course Expression of MicroRNA-223 by Neutrophils
Group B streptococcus (GBS) is a human pathogenic bacteria inducing a strong inflammatory response that may be detrimental for host tissues if not finely regulated. The inflammatory response can be modulated by different molecular mechanisms, among which growing evidences point toward the crucial role of microRNAs. Regarding innate inflammatory response, studies have reported that miR-223 is essential for the control of granulocyte proliferation and activation. Moreover, number of investigations on miRNA expression profiling performed in various inflammatory settings reveal that miR-223 is among the top differentially expressed miRNA. Yet, the dynamic pattern of expression of miR-223 in vivo with respect to the evolution of the inflammatory process, especially in microbial infection, remains elusive. In this study, we analyzed the kinetic expression of miR-223 in an inflammatory model of GBS-induced murine pneumoniae and looked for correlates with inflammatory markers including innate cell infiltrates. We found that miR-223 expression is rapidly induced at very early time points (3-6 h post infection) mainly by lung infiltrating neutrophils. Interestingly, the level of miR-223 accumulating in the lungs remains higher at later stages of infection (24h and 48h pi) and this correlates with reduced expression of primary inflammatory cytokines and chemokines and with a shift in infiltrating monocyte and macrophage subtypes toward regulatory phenotype. Transient inhibition of miR223 by an antagomir resulted in significant increase of CXCL2 expression and partial enhancing of infiltrating neutrophils in GBS infected lung tissues. This suggests the potential contribution of miR-223 to the resolution phase of GBS-induced acute inflammation.
- 16 November 2020
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 88 (12)
Progressive Control of Streptococcus agalactiae-Induced Innate Inflammatory Response Is Associated with Time Course Expression of MicroRNA-223 by Neutrophils
Group B streptococcus (GBS) is a human pathogenic bacteria inducing a strong inflammatory response that may be detrimental for host tissues if not finely regulated. The inflammatory response can be modulated by different molecular mechanisms, among which growing evidences point toward the crucial role of microRNAs. Regarding innate inflammatory response, studies have reported that miR-223 is essential for the control of granulocyte proliferation and activation. Moreover, number of investigations on miRNA expression profiling performed in various inflammatory settings reveal that miR-223 is among the top differentially expressed miRNA. Yet, the dynamic pattern of expression of miR-223 in vivo with respect to the evolution of the inflammatory process, especially in microbial infection, remains elusive. In this study, we analyzed the kinetic expression of miR-223 in an inflammatory model of GBS-induced murine pneumoniae and looked for correlates with inflammatory markers including innate cell infiltrates. We found that miR-223 expression is rapidly induced at very early time points (3-6 h post infection) mainly by lung infiltrating neutrophils. Interestingly, the level of miR-223 accumulating in the lungs remains higher at later stages of infection (24h and 48h pi) and this correlates with reduced expression of primary inflammatory cytokines and chemokines and with a shift in infiltrating monocyte and macrophage subtypes toward regulatory phenotype. Transient inhibition of miR223 by an antagomir resulted in significant increase of CXCL2 expression and partial enhancing of infiltrating neutrophils in GBS infected lung tissues. This suggests the potential contribution of miR-223 to the resolution phase of GBS-induced acute inflammation.
- Open Access
- 25 September 2020
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 7
Understanding Gender-Bias in Critically Ill Patients With COVID-19
Understanding Gender-Bias in Critically Ill Patients With COVID-19
- 25 September 2020
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 7
Open AccessUnderstanding Gender-Bias in Critically Ill Patients With COVID-19
Understanding Gender-Bias in Critically Ill Patients With COVID-19
- Open Access
- 5 February 2019
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 10, 107
Editorial: Sexual Dimorphism of the Immune Inflammatory Response in Infectious and Non-infectious Diseases
Editorial: Sexual Dimorphism of the Immune Inflammatory Response in Infectious and Non-infectious Diseases
- 5 February 2019
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 10, 107
Open AccessEditorial: Sexual Dimorphism of the Immune Inflammatory Response in Infectious and Non-infectious Diseases
Editorial: Sexual Dimorphism of the Immune Inflammatory Response in Infectious and Non-infectious Diseases
- Open Access
- 13 December 2017
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 8, 1806
Differential Susceptibility to Infectious Respiratory Diseases between Males and Females Linked to Sex-Specific Innate Immune Inflammatory Response
It is widely acknowledged that males and females exhibit contrasting degrees of susceptibility to infectious and non-infectious inflammatory diseases. This is particularly observed in respiratory diseases where human males are more likely to be affected by infection-induced acute inflammations compared to females. The type and magnitude of the innate immune inflammatory response play a cardinal role in this sex bias. Animal models mimicking human respiratory diseases have been used to address the biological factors that could explain the distinct outcomes. In this review, we focus on our current knowledge about experimental studies investigating sex-specific differences in infection-induced respiratory diseases and we provide an update on the most important innate immune mechanisms that could explain sex bias of the inflammatory response. We also discuss whether conclusions drawn from animal studies could be relevant to human.
- 13 December 2017
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 8, 1806
Open AccessDifferential Susceptibility to Infectious Respiratory Diseases between Males and Females Linked to Sex-Specific Innate Immune Inflammatory Response
It is widely acknowledged that males and females exhibit contrasting degrees of susceptibility to infectious and non-infectious inflammatory diseases. This is particularly observed in respiratory diseases where human males are more likely to be affected by infection-induced acute inflammations compared to females. The type and magnitude of the innate immune inflammatory response play a cardinal role in this sex bias. Animal models mimicking human respiratory diseases have been used to address the biological factors that could explain the distinct outcomes. In this review, we focus on our current knowledge about experimental studies investigating sex-specific differences in infection-induced respiratory diseases and we provide an update on the most important innate immune mechanisms that could explain sex bias of the inflammatory response. We also discuss whether conclusions drawn from animal studies could be relevant to human.
- 24 September 2009
- Published by Taylor & Francis in Immunopharmacology and Immunotoxicology
- Vol. 0 (0) , 1-4
Immunomodulation using genetically engineered bacteria for type III-mediated delivery of heterologous antigens and cytokines: Potential application in vaccine and therapeutical developments
The rational design of new approaches aiming to improve antigen or drug delivery remains a major challenge in numerous vaccine and therapeutical strategies. Studies on genetically engineered bacteria have led to significant progress in the delivery of heterologous proteins. Yet, the efficiency of such recombinant bacteria relies particularly on their ability to deliver sufficient amount of the drug to intended cell tissues. Gram-negative bacteria like Salmonella, Shigella, Yersinia and Pseudomonas have evolved powerful secretion machinery called type III secretion system (T3SS) that is used to optimize their virulence effect by delivering bacterial effectors to the membrane or into the host cell cytoplasm. This review highlights recent studies unraveling whether T3SS of attenuated bacteria could be an efficient route for delivery of vaccine antigens or bioactive proteins such as cytokines for immunomodulation that could find a broad range of application purposes. These current experimental investigations can be considered proofs of concept that need to be translated readily to effective vaccines and therapeutics in humans.JOURNAL ARTICLESCOPUS: re.jinfo:eu-repo/semantics/publishe
- 24 September 2009
- Published by Taylor & Francis in Immunopharmacology and Immunotoxicology
- Vol. 0 (0) , 1-4
Immunomodulation using genetically engineered bacteria for type III-mediated delivery of heterologous antigens and cytokines: Potential application in vaccine and therapeutical developments
The rational design of new approaches aiming to improve antigen or drug delivery remains a major challenge in numerous vaccine and therapeutical strategies. Studies on genetically engineered bacteria have led to significant progress in the delivery of heterologous proteins. Yet, the efficiency of such recombinant bacteria relies particularly on their ability to deliver sufficient amount of the drug to intended cell tissues. Gram-negative bacteria like Salmonella, Shigella, Yersinia and Pseudomonas have evolved powerful secretion machinery called type III secretion system (T3SS) that is used to optimize their virulence effect by delivering bacterial effectors to the membrane or into the host cell cytoplasm. This review highlights recent studies unraveling whether T3SS of attenuated bacteria could be an efficient route for delivery of vaccine antigens or bioactive proteins such as cytokines for immunomodulation that could find a broad range of application purposes. These current experimental investigations can be considered proofs of concept that need to be translated readily to effective vaccines and therapeutics in humans.JOURNAL ARTICLESCOPUS: re.jinfo:eu-repo/semantics/publishe
- Open Access
- 15 March 2008
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 180 (6) , 4292-4298
Delivery of Biologically Active Anti-Inflammatory Cytokines IL-10 and IL-1ra In Vivo by the Shigella Type III Secretion Apparatus
Pathogenicity of many Gram-negative bacteria relies on a type III secretion (T3S) apparatus, which is used for delivery of bacterial effectors into the host cell cytoplasm allowing the bacteria to manipulate host cell cytoskeleton network as well as to interfere with intracellular signaling pathways. In this study, we investigated the potential of the Shigella flexneri T3SA as an in vivo delivery system for biologically active molecules such as cytokines. The anti-inflammatory cytokines IL-10 and IL-1 receptor antagonist (IL-1ra) were genetically fused to the first 30 or 60 residues of the Shigella T3S effector IpaH9.8 or to the first 50 residues of the Yersinia enterocolitica effector YopE and the recombinant fusion proteins were expressed in S. flexneri. YopE50-IL-10, IpaH60-IL-10, and IpaH60-IL-1ra were efficiently secreted via the T3S apparatus of Shigella. Moreover, these recombinant proteins did not impair the invasive ability of the bacteria in vitro. In a murine model, Shigella strains expressing YopE50-IL-10, IpaH60-IL-10, and IpaH60-IL-1ra induced a lower mortality in mice that was associated with reduced inflammation and a restricted localization of bacteria within the lung tissues as compared with wild-type Shigella. Moreover, the level of TNF-α and IL-1β mRNA were reduced in the lungs following infection by IL-10- and IL-1ra-secreting Shigella, respectively. These findings demonstrate that the Shigella T3S apparatus can deliver biologically active cytokines in vivo, thus opening new avenues for the use of attenuated bacteria to deliver proteins for immunomodulation or gene therapy purposes.
- 15 March 2008
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 180 (6) , 4292-4298
Open AccessDelivery of Biologically Active Anti-Inflammatory Cytokines IL-10 and IL-1ra In Vivo by the Shigella Type III Secretion Apparatus
Pathogenicity of many Gram-negative bacteria relies on a type III secretion (T3S) apparatus, which is used for delivery of bacterial effectors into the host cell cytoplasm allowing the bacteria to manipulate host cell cytoskeleton network as well as to interfere with intracellular signaling pathways. In this study, we investigated the potential of the Shigella flexneri T3SA as an in vivo delivery system for biologically active molecules such as cytokines. The anti-inflammatory cytokines IL-10 and IL-1 receptor antagonist (IL-1ra) were genetically fused to the first 30 or 60 residues of the Shigella T3S effector IpaH9.8 or to the first 50 residues of the Yersinia enterocolitica effector YopE and the recombinant fusion proteins were expressed in S. flexneri. YopE50-IL-10, IpaH60-IL-10, and IpaH60-IL-1ra were efficiently secreted via the T3S apparatus of Shigella. Moreover, these recombinant proteins did not impair the invasive ability of the bacteria in vitro. In a murine model, Shigella strains expressing YopE50-IL-10, IpaH60-IL-10, and IpaH60-IL-1ra induced a lower mortality in mice that was associated with reduced inflammation and a restricted localization of bacteria within the lung tissues as compared with wild-type Shigella. Moreover, the level of TNF-α and IL-1β mRNA were reduced in the lungs following infection by IL-10- and IL-1ra-secreting Shigella, respectively. These findings demonstrate that the Shigella T3S apparatus can deliver biologically active cytokines in vivo, thus opening new avenues for the use of attenuated bacteria to deliver proteins for immunomodulation or gene therapy purposes.
- Open Access
- 5 April 2007
- Published by Hindawi Limited in Journal of Biomedicine and Biotechnology
- Vol. 2007 (3) , 1-6
CD40-CD40L Interaction in Immunity Against Protozoan Infections
Activation of the immune system against protozoan infections relies particularly on two specific signals provided by cognate interaction of T cells with antigen presenting cells (APCs). The first signal is attributed to binding of the T-cell receptor (TCR) to peptide/MHC complexes on the surface of APCs, whereas the second signal is triggered through binding of several costimulatory molecules on the surface of APCs with their corresponding receptors on T cells. Among these costimulatory signallings, CD40/CD40L interactions have been particularly investigated in protozoan infection models with regard to their potential to amplify cell-mediated immunity against intracellular parasites. This article reviews current studies of the potential role of CD40/CD40L interaction in the modulation of immune responses against some protozoan parasites and highlights recent developments regarding manipulation of this interaction for promoting control of parasite infections.
- 5 April 2007
- Published by Hindawi Limited in Journal of Biomedicine and Biotechnology
- Vol. 2007 (3) , 1-6
Open AccessCD40-CD40L Interaction in Immunity Against Protozoan Infections
Activation of the immune system against protozoan infections relies particularly on two specific signals provided by cognate interaction of T cells with antigen presenting cells (APCs). The first signal is attributed to binding of the T-cell receptor (TCR) to peptide/MHC complexes on the surface of APCs, whereas the second signal is triggered through binding of several costimulatory molecules on the surface of APCs with their corresponding receptors on T cells. Among these costimulatory signallings, CD40/CD40L interactions have been particularly investigated in protozoan infection models with regard to their potential to amplify cell-mediated immunity against intracellular parasites. This article reviews current studies of the potential role of CD40/CD40L interaction in the modulation of immune responses against some protozoan parasites and highlights recent developments regarding manipulation of this interaction for promoting control of parasite infections.